Literature DB >> 9708949

REAL classification of malignant lymphomas in the Republic of Korea: incidence of recently recognized entities and changes in clinicopathologic features. Hematolymphoreticular Study Group of the Korean Society of Pathologists. Revised European-American lymphoma.

Y H Ko1, C W Kim, C S Park, H K Jang, S S Lee, S H Kim, H J Ree, J D Lee, S W Kim, J R Huh.   

Abstract

BACKGROUND: The clinicopathologic characteristics of malignant lymphomas vary according to geography. The aim of this study was to determine the clinical characteristics of malignant lymphomas and the relative frequency in the Republic of Korea of lymphomas belonging to the newly described REAL (revised European-American lymphoma) classification categories.
METHODS: The Hematolymphoreticular Study Group of the Korean Society of Pathologists conducted a consensus-based morphologic review of a nationwide collection of 1548 malignant lymphomas, including Hodgkin's disease (HD), diagnosed at 23 institutes over a recent 2-year period. Slides stained with hematoxylin and eosin or other immunohistochemical stains were reviewed. All cases were classified according to the histologic criteria proposed by the International Lymphoma Study Group. Clinical data, including age, gender, and site of disease involvement, were reviewed.
RESULTS: The Republic of Korea had lower rates of HD and follicle center lymphoma and higher rates of extranodal lymphoma, diffuse large B-cell lymphoma, and angiocentric lymphoma compared with Western countries. The most frequent subtypes of non-Hodgkin's lymphoma (NHL) were diffuse large B-cell lymphoma, extranodal marginal zone B-cell lymphoma, peripheral T-cell lymphoma, unspecified type, and angiocentric lymphoma, in decreasing order. Compared with a previous nationwide study, the rates for follicular lymphoma and NHL involving the stomach, orbit, and central nervous system were increased. The rate of T-cell NHL in the current study was much lower than that reported in a previous study for the Republic of Korea and was also lower than that reported for other Far East countries. For HD, the relative frequency of nodular sclerosis subtype was higher compared with that in the previous study, and lymphocyte predominance and lymphocyte depletion were lower.
CONCLUSIONS: The occurrence rates for various subtypes of malignant lymphoma in the Republic of Korea are distinct from those in Western countries and similar in many ways to those in other countries in the Far East. Compared with other Far East countries, the Republic of Korea has a higher rate of extranodal lymphoma, rare adult T-cell lymphoma, and a relatively low rate of T-cell lymphomas. It appears that over time there have been changes in the relative rates for follicular lymphoma, subtypes of Hodgkin's disease, and gastric and orbital lymphoma. The authors attribute these changes primarily to refined criteria for diagnosing new clinicopathologic entities.

Entities:  

Mesh:

Year:  1998        PMID: 9708949

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  48 in total

1.  Striking male predominance of mantle cell lymphoma in Taiwan.

Authors:  S-S Chuang; W-T Huang; P-P Hsieh; H-H Tseng; H-M Chang
Journal:  J Clin Pathol       Date:  2006-07       Impact factor: 3.411

2.  High-dose therapy and autologous stem cell transplantation in peripheral T-cell lymphoma: treatment outcome and prognostic factor analysis.

Authors:  Lin Gui; Yuan-kai Shi; Xiao-hui He; Ying-heng Lei; Hong-zhi Zhang; Xiao-hong Han; Sheng-yu Zhou; Peng Liu; Jiang-liang Yang; Mei Dong; Chang-gong Zhang; Sheng Yang; Yan Qin
Journal:  Int J Hematol       Date:  2013-11-21       Impact factor: 2.490

3.  Quality of life one year after chemoradiotherapy for localized primary gastric diffuse large B-cell lymphoma.

Authors:  Won Seog Kim; Yeon Hee Park; Se-Hoon Lee; Baek-Yeol Ryoo; Sung Hyun Yang; Seung-Sook Lee; Mi Sook Kim; Kihyun Kim; Keon Woo Park; Do Hyoung Im; Jung Hun Kang; Jeeyun Lee; Young H Ko; Yong Chan Ahn; Do Hoon Lim; Keunchil Park; Soo-Mee Bang
Journal:  Med Oncol       Date:  2008-04-23       Impact factor: 3.064

4.  Treatment outcome of radiotherapy alone versus radiochemotherapy in early stage nasal natural killer/T-cell lymphoma.

Authors:  Hui-Hui Ma; Li-Ting Qian; Hai-Feng Pan; Lin Yang; Hong-Yan Zhang; Zhi-Hua Wang; Jun Ma; Yu-Fei Zhao; Jin Gao; Ai-Dong Wu
Journal:  Med Oncol       Date:  2009-08-15       Impact factor: 3.064

5.  Synchronous perforation of non-Hodgkin's lymphoma of the small intestine and colon: a case report.

Authors:  Mohamad S Dughayli; Fadi Baidoun; Aaron Lupovitch
Journal:  J Med Case Rep       Date:  2011-02-10

Review 6.  Peripheral T-cell lymphoma.

Authors:  Wing Y Au; Raymond Liang
Journal:  Curr Oncol Rep       Date:  2002-09       Impact factor: 5.075

7.  Primary systemic anaplastic large cell lymphoma in a single Korean institution: clinical characteristics and treatment outcome.

Authors:  Sook Ryun Park; Ji Yeon Baek; Dong-Wan Kim; Seok-Ah Im; Tae-You Kim; Yung-Jue Bang; Noe Kyeong Kim; Yoon Kyung Jeon; Chul Woo Kim; Dae Seog Heo
Journal:  J Korean Med Sci       Date:  2006-08       Impact factor: 2.153

8.  De novo CD5 positive diffuse large B-cell lymphomas with bone marrow involvement in Korean.

Authors:  Sun-Young Kong; Eun Hae Cho; Hee Yeon Woo; Qeuhn Park; Young Hyeh Ko; Sun-Hee Kim
Journal:  J Korean Med Sci       Date:  2004-12       Impact factor: 2.153

9.  The clinical characteristics and treatment results of ocular adnexal lymphoma.

Authors:  Jung-Min Woo; Chien-Kue Tang; Mee-Sook Rho; Jin-Hwa Lee; Hyuk-Chan Kwon; Hee-Bae Ahn
Journal:  Korean J Ophthalmol       Date:  2006-03

10.  Modified number of extranodal involved sites as a prognosticator in R-CHOP-treated patients with disseminated diffuse large B-cell lymphoma.

Authors:  Changhoon Yoo; Shin Kim; Byeong Seok Sohn; Jeong-Eun Kim; Dok Hyun Yoon; Jooryung Huh; Dae Ho Lee; Sang-We Kim; Jung-Shin Lee; Cheolwon Suh
Journal:  Korean J Intern Med       Date:  2010-08-31       Impact factor: 2.884

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.